The Safety of Drug-Eluting Stents: Early Release from the New England Journal of Medicine (Free Full Text)

"Because of the current public interest in this topic, the following articles and commentary were published on February 12, 2007, at www.nejm.org. They will appear in the March 8 issue of the Journal." Original Article A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents C. Spaulding and Others Original Article Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents G.W. Stone and Others Original Article Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden B. Lagerqvist and Others Original Article Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents L. Mauri and Others Original Article Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents A. Kastrati and Others Editorial Drug-Eluting Coronary Stents — Promise and Uncertainty (with animated figure) G.D. Curfman and Others Perspective Unanswered Questions — Drug-Eluting Stents and the Risk of Late Thrombosis W.H. Maisel Perspective Stent Thrombosis Redux — The FDA Perspective A. Farb and A.B. Boam An audio interview with Donald Baim and Steven Nissen